These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2642859)
1. Pancreas-specific protein. New serum marker for graft rejection in pancreas-transplant recipients. Fernstad R; Tydén G; Brattström C; Sköldefors H; Carlström K; Groth CG; Pousette A Diabetes; 1989 Jan; 38 Suppl 1():55-6. PubMed ID: 2642859 [TBL] [Abstract][Full Text] [Related]
2. A novel assay for pancreatic cellular damage: III. Use of a pancreas-specific protein as a marker of pancreatic graft dysfunction in humans. Fernstad R; Sköldefors H; Pousette A; Groth CG; Tydén G; Ost L; Lindholm A; Carlström K Pancreas; 1989; 4(1):44-52. PubMed ID: 2654929 [TBL] [Abstract][Full Text] [Related]
3. Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simultaneous pancreas and kidney transplantation. Müller TF; Trösch F; Ebel H; Grüssner RW; Feiber H; Göke B; Greger B; Lange H Transpl Int; 1997; 10(3):185-91. PubMed ID: 9163857 [TBL] [Abstract][Full Text] [Related]
4. Isoforms of procarboxypeptidase B, (pancreas-specific protein, PASP) in human serum, pancreatic tissue and juice. Fernstad R; Kylander C; Tsai L; Tydén G; Pousette A Scand J Clin Lab Invest Suppl; 1993; 213():9-17. PubMed ID: 8322019 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
7. Pancreas specific protein (PASP) monitoring in pancreas transplantation. Nyberg G; Olausson M; Nordén G; Mjörnstedt L; Blohmé I; Hedman L Transplant Proc; 1991 Feb; 23(1 Pt 2):1604-5. PubMed ID: 1989305 [No Abstract] [Full Text] [Related]
8. Plasma pancreatic secretory trypsin inhibitor as a marker of pancreas graft rejection after combined pancreas-kidney transplantation. Suzuki Y; Kuroda Y; Sollinger HW; Reed AI; Hullett DA; Saitoh Y Transplantation; 1991 Sep; 52(3):504-7. PubMed ID: 1897024 [TBL] [Abstract][Full Text] [Related]
9. A three-year experience with serum anodal trypsinogen as a biochemical marker for rejection in pancreatic allografts. False positives, tissue biopsy, comparison with other markers, and diagnostic strategies. Perkal M; Marks C; Lorber MI; Marks WH Transplantation; 1992 Feb; 53(2):415-9. PubMed ID: 1371196 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of pancreatic amylase and pancreas-specific protein as markers of pancreatic graft rejection episodes. Minakawa R; Brattström C; Tydén G; Tibell A; Pousette A; Bergström K Transplant Proc; 1995 Feb; 27(1):1329-30. PubMed ID: 7533379 [No Abstract] [Full Text] [Related]
16. Elevated C-peptide Levels Are Associated With Acute Rejection in Kidney Pancreas Transplantation. Xie WY; McAlister VC; Fiorini K; Sener A; Luke PP Transplant Proc; 2020 Apr; 52(3):987-991. PubMed ID: 32143871 [TBL] [Abstract][Full Text] [Related]
17. Plasma complement 3d levels in the early phase after pancreas transplantation. Suermann A; Vonend O; Schenker P; Viebahn R; Rump LC; Weiner SM Ann Transplant; 2009; 14(3):29-35. PubMed ID: 19644157 [TBL] [Abstract][Full Text] [Related]
18. Causes of graft failure in simultaneous pancreas-kidney transplantation by various time periods. Wakil K; Sugawara Y; Kokudo N; Kadowaki T Clin Transpl; 2013; ():23-30. PubMed ID: 25095489 [TBL] [Abstract][Full Text] [Related]